Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Meier

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Der Internist|January 23, 2016
[Treatment of type 2 diabetes]J J Meier
Diabetologia|March 5, 2008
Beta cell mass in diabetes: a realistic therapeutic target?J J Meier
Alumni Bulletin - School of Dentistry, Indiana University|January 1, 1977
Private dental practice: the first yearJ J Meier
Der Internist|February 1, 2017
[Cardiovascular effects of liraglutide therapy in patients with type 2 diabetes : Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results (LEADER)]J J Meier, S Nitschmann
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|January 19, 2005
GIP as a potential therapeutic agent?J J Meier, M A Nauck
Diabetologia|September 28, 2007
The enteroinsular axis may mediate the diabetogenic effects of TCF7L2 polymorphismsM A Nauck, J J Meier
Der Internist|June 2, 2007
[New concepts in the treatment of type 2 diabetes]J J Meier, W E Schmidt, H H Klein
Diabetologia|February 2, 2006
Comment to: Patti ME, McMahon G, Mun EC et al. (2005) Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia. Diabetologia 48:2236-2240J J Meier, M A Nauck, P C Butler
Zeitschrift Fur Gastroenterologie|September 18, 2003
[Appetite regulation by ghrelin - a novel neuro-endocrine gastric peptide hormone in the gut-brain-axis]D Hagemann, J J Meier, B Gallwitz, et al.
Diabetologia|June 11, 2013
Do current incretin mimetics exploit the full therapeutic potential inherent in GLP-1 receptor stimulation?M A Nauck, O Baranov, R A Ritzel, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Der Internist|January 23, 2016
[Treatment of type 2 diabetes]J J Meier
Diabetologia|March 5, 2008
Beta cell mass in diabetes: a realistic therapeutic target?J J Meier
Alumni Bulletin - School of Dentistry, Indiana University|January 1, 1977
Private dental practice: the first yearJ J Meier
Der Internist|February 1, 2017
[Cardiovascular effects of liraglutide therapy in patients with type 2 diabetes : Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results (LEADER)]J J Meier, S Nitschmann
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|January 19, 2005
GIP as a potential therapeutic agent?J J Meier, M A Nauck
Diabetologia|September 28, 2007
The enteroinsular axis may mediate the diabetogenic effects of TCF7L2 polymorphismsM A Nauck, J J Meier
Der Internist|June 2, 2007
[New concepts in the treatment of type 2 diabetes]J J Meier, W E Schmidt, H H Klein
Diabetologia|February 2, 2006
Comment to: Patti ME, McMahon G, Mun EC et al. (2005) Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia. Diabetologia 48:2236-2240J J Meier, M A Nauck, P C Butler
Zeitschrift Fur Gastroenterologie|September 18, 2003
[Appetite regulation by ghrelin - a novel neuro-endocrine gastric peptide hormone in the gut-brain-axis]D Hagemann, J J Meier, B Gallwitz, et al.
Diabetologia|June 11, 2013
Do current incretin mimetics exploit the full therapeutic potential inherent in GLP-1 receptor stimulation?M A Nauck, O Baranov, R A Ritzel, et al.
Pageof 5